Expert Review Logo
Welcome Guest user | Log in | Athens Login | Shibboleth Login | Register
Resources
Register
For Authors
For Librarians
For Advertisers
Services
Subscriptions/Pricing
Reprints
Advertising
Press Releases/News
Help
Downloads/Links
2008/9 Catalogue
Library Recommendation
Summary
August 2007, Vol. 6, No. 4, Pages 527-537 , DOI 10.1586/14760584.6.4.527
(doi:10.1586/14760584.6.4.527)

Review
Functionality of the immune system in patients with chronic hepatitis C: trial by superinfections and vaccinations
Maria G Isaguliants



Viral infections, specifically chronic, markedly influence the host response to subsequent infections and vaccinations. Does this apply to chronic hepatitis C (CHC)? The review considers this question with implications for the immune status and functionality of the immune system of a chronically HCV-infected host. The data collected here indicate that CHC may increase the risk of viral superinfections and modify their course by immunocompromising the host. Patients with CHC do not lose the ‘memory’ of previous infections and vaccinations but, apparently, have problems with building such immunity anew, as illustrated by their impaired response to hepatitis A and B vaccinations. This underlines the necessity of extra protection of CHC patients against blood-borne diseases, hepatitis A, possibly also varicella, influenza, tetanus, and diphtheria – immunity to which, in the Western population, appears to falter. Such immune protection has to be adapted to selective impairments of immune response characteristic to CHC. Some approaches to this are reviewed here and more need to be elaborated. Special attention has to be given to CHC patients who do not respond to common vaccines; further studies in this field are of great interest.

Full Text PDF (143 KB) PDF Plus (274 KB)

Users who read this article also read:

Immunotherapy for HCV infection: next steps
Krystle Lang, David B Weiner
Expert Review of Vaccines, Sep 2008, Vol. 7, No. 7, Pages 915-923.
Summary | Full Text | PDF (438 KB) | PDF Plus (499 KB) | Add to Favorites | Related 
 New therapeutic prospects in HCV treatment
Piero Luigi Almasio, Daniela Ingrassia, Beatrice Vergara, Sergio Filosto
Expert Review of Anti-infective Therapy, Dec 2008, Vol. 6, No. 6, Pages 775-779.
Citation | Full Text | PDF (1702 KB) | PDF Plus (1664 KB) | Add to Favorites | Related 
Resistance mechanisms in HCV: from evolution to intervention
Arthur Y Kim, Joerg Timm
Expert Review of Anti-infective Therapy, Aug 2008, Vol. 6, No. 4, Pages 463-478.
Summary | Full Text | PDF (1797 KB) | PDF Plus (1838 KB) | Add to Favorites | Related 
Cellular vaccine therapy for cancer
Anne C Armstrong, David Eaton, Joanne C Ewing
Expert Review of Vaccines, Oct 2002, Vol. 1, No. 3, Pages 303-316.
Summary | PDF (224 KB) | PDF Plus (336 KB) | Add to Favorites | Related 
 

Prev. Article | Next Article
View/Print PDF (143 KB)
View PDF Plus (274 KB)
Add to favorites
Email to a friend
TOC Alert | Citation Alert What is RSS?

 
 
Quick Search
for 
Author:
Maria G Isaguliants
Keywords:
adult vaccine
antigen presentation
GBV-C/HGV
HAV
HBV
hepatitis C virus
HIV
immune system
impairment
influenza
recall antigen
TTV
vaccination


Expert Reviews Ltd, Unitec House, 2 Albert Place, London, N3 1QB, UK
Business Office: Tel +44 (0)20 8371 6080 · Fax +44 (0)20 8371 6099 
Editorial Office: Tel +44 (0)20 8371 6090 · Fax +44 (0)20 8343 2313
We welcome your Feedback. See our Privacy Statement and Terms and Conditions.